15 November 2019

Getting to the Heart of Data, Bioinformatics and Personalised Care.

By Jack Maclean

Data is the new oil of the 21st Century.”

2006, Clive Humby, Mathematician & Architect of the Tesco Clubcard

 

It’s quite a bold claim, on a topic that’s far too broad to speak about in this manner. Reigning in Clive’s words a little, I agree that data is everything... in healthcare.

Heading into the world of personalised care, data insights are providing us with more effective, targeted and preventative treatments for patients. 

The dependence on data is so strong, that discovering these actionable insights for personalised care has led to the emergence of a new area of study and investment, bioinformatics.

Bioinformatics is the science of storing, retrieving and analysing large amounts of biological information, like DNA/protein sequences. It’s a highly interdisciplinary field involving many different types of specialists, including biologists, molecular life scientists, computer scientists and mathematicians.

This is an essential piece of the personalised care puzzle, with the biological data that bioinformatics provides helping identify patients susceptible to certain diseases, which are then proactively treated before the patient falls ill. 

Data is a key part of bioinformatics, meaning that any integration with AI is an exciting prospect. This could lead to the eradication of human error, whilst also making processes quicker and more automated. 

The algorithms required for a variety of bioinformatics processes are becoming increasingly complex, with the development of computers and software struggling to keep up. This is where AI can step in to bridge the gap. 

Integrating AI into Bioinformatics has already led to an array of developments in the field, including faster image analysis, which can result in much earlier diagnosis of multiple types of cancer. 

The major advantage of employing AI within bioinformatics for genome annotation is its ability to automatically identify patterns in a huge amount of data. 

Using data, advanced AI identifies these patterns through machine learned software and algorithms that it can develop far quicker and more accurate than any human. Advanced AI can also learn from mistakes and previous actions, resulting in a complete lack of errors for algorithms or types of software which are adapted to different uses.

Using AI can also lead to advantages in the collection and storage of data from various research and activities, such as gene expression. Instructing AI to collect data, store it, and present data eliminates the chance of human coding ad input error, which can result to errors in the database. This can have a knock-on effect for other experiments or findings where this database is referred to.

With so many advantages, there’s some fear among bioinformaticians that AI could make their role in bioinformatics redundant. However, I don’t believe this is a cause for concern. Their skills are transferable and will be invaluable in the complex process of AI integration. Furthermore, there’s still some apprehension and trust issues surrounding AI, meaning that for now a manned presence will be preferred. But don't let this point detract from the fact that AI intergration will almost certainly lead to huge time and cost savings. 

As I said at the start, I’m not getting into the ‘new oil of the 21st century’ debate... this is a quick reflection of what I’m seeing in my market. For healthcare, the future is clearly data-driven and a move to personalised care needs to be supported by bioinformatics and its integration with AI.

 

Share
Back to the top
By Jack Maclean

Jack Maclean is a specialist in the Bioinformatics space, working with a range of exciting Biotech companies who focus on bioinformatics and data science. Specialising in hires ranging from mid-management to C-Level appointments, Jack boasts an international network dedicated completely to this space.

Recommended.

Getting to the Heart of Data, Bioinformatics and Personalised Care.
15 November 2019 By Jack Maclean

Getting to the Heart of Data, Bioinformatics and Personalised Care.

Heading into the proactive world of personalised care, data insights are providing us with more effective, targeted and preventative treatments for patients.

To PhD or Not to PhD?
08 October 2019 By George Coe

To PhD or Not to PhD?

I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?

To PhD or Not to PhD?
08 October 2019 By George Coe

To PhD or Not to PhD?

I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?

What is the Point in Conferences?
19 August 2019 By Jack Shute

What is the Point in Conferences?

In today's hyper-connected world, what's the point of conferences? Our Associate Director Jack Shute asked experts from across the speciality chemical space and some of his CM Life Science colleagues to find out.

Get the latest into your inbox.